Adaptive Biotechnologies ADPT Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
Based on trailing twelve months.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's return on equity?
- Adaptive Biotechnologies (ADPT) reported return on equity of -24.4% in Q1 2026.
- How has Adaptive Biotechnologies's return on equity changed year-over-year?
- Adaptive Biotechnologies's return on equity increased by 59.9% year-over-year, from -61% to -24.4%.
- What is the long-term trend for Adaptive Biotechnologies's return on equity?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's return on equity has grown at a 4.9% compound annual growth rate (CAGR), from -22.3% to -28.2%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.